Product
DT-216
2 clinical trials
1 indication
Indication
Friedreich AtaxiaClinical trial
A Phase 1b, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose and Multi-Dose Study of DT-216 in Adult Patients With Friedreich AtaxiaStatus: Completed, Estimated PCD: 2023-08-25
Clinical trial
A Phase 1a, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study of DT-216 in Adult Patients With Friedreich AtaxiaStatus: Completed, Estimated PCD: 2022-12-19